Molecular Interactions
Last updated: 2025 Mar 18
Total hit(s): 5927
S.No.
1
39720838
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Expert Rev Vaccines
2025 Dec
4.37
1
2
39865693
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
3
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
4
40045463
The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants.
Hum Vaccin Immunother
2025 Dec
4.7
1
5
40046771
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct.
J Struct Biol X
2025 Jun
1
6
39987705
Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies.
Biophys Chem
2025 May-Jun
1.75
1
7
39894142
Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies.
Anal Biochem
2025 May
1
8
40043614
Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
Biochem Biophys Res Commun
2025 Apr 1
2.73
1
9
40025551
Association of TNFRSF13B Gene Polymorphisms With SARS-CoV-2 Infection, Severity, and Humoral Immune Response in a Moroccan Population.
Int J Immunogenet
2025 Apr
1
10
40037139
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
Virology
2025 Apr
2.819
1
11
40023068
Exploring the therapeutic potential of HAPC in COVID-19-induced acute lung injury.
Phytomedicine
2025 Apr
7.2
1
12
39999562
In silico tuning of binding selectivity for new SARS-CoV-2 main protease inhibitors.
Comput Methods Programs Biomed
2025 Apr
4.26
1
13
40057761
Impact of single nucleotide polymorphism of IL-27P28 rs153109 and IFITM3 rs12252 on susceptibility and severity of COVID-19 in Egyptian patients: a case control study.
Virol J
2025 Mar 8
2.45
1
14
39979118
Proteomics Reveals That Vitamin D Deficiency Leads to Immunoglobulin Abnormalities and Immune Dysregulation in Patients with Post-COVID-19 Condition.
J Proteome Res
2025 Mar 7
3.8
1
15
40056829
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2.
Biomed Pharmacother
2025 Mar 7
3.83
1
16
40042313
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies.
mBio
2025 Mar 5
6.5
1
17
40044778
Performance assessment of disposable carbon-based immunosensors for the detection of SARS-CoV-2 infections.
Sci Rep
2025 Mar 5
4.12
1
18
40049248
Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in rats.
Reprod Toxicol
2025 Mar 4
1
19
40025489
Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection.
BMC Biol
2025 Mar 3
1
20
40037239
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil.
Vaccine
2025 Mar 3
3.31
1
21
40044551
Electrochemical pan-variant detection of SARS-CoV-2 through host cell receptor-mimicking molecular recognition.
Biosens Bioelectron
2025 Mar 3
9.52
1
22
39962897
Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain.
Inorg Chem
2025 Mar 3
1
23
40060909
Mutational pressure promotes release of public CD8(+) T cell epitopes by proteasome from SARS-CoV-2 RBD of Omicron and its current lineages.
iScience
2025 Mar 21
4.447
1
24
39970838
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in mice.
Biochem Biophys Res Commun
2025 Mar 19
2.73
1
25
40096751
Efficient one-step immobilization of DNA probes on 1DZnO nanoplatforms targeting a low-mutation region of SARS-CoV-2.
Biofabrication
2025 Mar 17
1